Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs
Open Access
- 21 November 2017
- journal article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 37 (6)
- https://doi.org/10.1042/bsr20171161
Abstract
Determining drug-metabolizing enzyme activities on an individual basis is an important component of personalized medicine, and cytochrome P450 enzymes (CYPs) play a principal role in hepatic drug metabolism. Herein, a simple method for predicting the major CYP-mediated drug clearance in vitro and in vivo is presented. Ten CYP-mediated drug metabolic activities in human liver microsomes (HLMs) from 105 normal liver samples were determined. The descriptive models for predicting the activities of these CYPs in HLMs were developed solely on the basis of the measured activities of a smaller number of more readily assayed CYPs. The descriptive models then were combined with the Conventional Bias Corrected in vitro–in vivo extrapolation method to extrapolate drug clearance in vivo. The Vmax, Km, and CLint of six CYPs (CYP2A6, 2C8, 2D6, 2E1, and 3A4/5) could be predicted by measuring the activities of four CYPs (CYP1A2, 2B6, 2C9, and 2C19) in HLMs. Based on the predicted CLint, the values of CYP2A6-, 2C8-, 2D6-, 2E1-, and 3A4/5-mediated drug clearance in vivo were extrapolated and found that the values for all five drugs were close to the observed clearance in vivo. The percentage of extrapolated values of clearance in vivo which fell within 2-fold of the observed clearance ranged from 75.2% to 98.1%. These findings suggest that measuring the activity of CYP1A2, 2B6, 2C9, and 2C19 allowed us to accurately predict CYP2A6-, 2C8-, 2D6-, 2E1-, and 3A4/5-mediated activities in vitro and in vivo and may possibly be helpful for the assessment of an individual’s drug metabolic profile.Keywords
This publication has 56 references indexed in Scilit:
- Formation of P450·P450 complexes and their effect on P450 functionPharmacology & Therapeutics, 2012
- Functional Evaluation of Genetic and Environmental Regulators of P450 mRNA LevelsPLOS ONE, 2011
- Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liverGenome Research, 2010
- Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo SimulationDrug Metabolism and Disposition, 2010
- Intravenous dextromethorphan to human volunteers: relationship between pharmacokinetics and anti-hyperalgesic effectPain, 2005
- Regulation of Cytochrome P450 by Posttranslational ModificationDrug Metabolism Reviews, 2005
- Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humansBritish Journal of Clinical Pharmacology, 2003
- The Influence of Parecoxib, a Parenteral Cyclooxygenase-2 Specific Inhibitor, on the Pharmacokinetics and Clinical Effects of MidazolamAnesthesia & Analgesia, 2002
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976